Warren, Travis K.
Kane, Christopher D.
Wells, Jay
Stuthman, Kelly S.
Van Tongeren, Sean A.
Garza, Nicole L.
Donnelly, Ginger
Steffens, Jesse
Gomba, Laura
Weidner, Jessica M.
Norris, Sarah
Zeng, Xiankun
Bannister, Roy
Cihlar, Tomas
Bavari, Sina
Porter, Danielle P.
Iversen, Patrick L.
Funding for this research was provided by:
US Army Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Defense Medical under (W911QY-16-9-0001)
Article History
Received: 6 May 2021
Accepted: 2 September 2021
First Online: 30 September 2021
Competing interests
: R.B., T.C., and D.P.P. are current employees, and may be shareholders, of Gilead Sciences. All other authors report no potential conflicts.